ChemFeeds Site Navigation:
Journal Selection:
Search:

1) Correction: The Phosphoinositide 3-Kinase {alpha} Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


2) Correction: Driven to Death: Inhibition of Farnesylation Increases Ras Activity in Osteosarcoma and Promotes Growth Arrest and Cell Death (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


3) Correction: Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-{kappa}B Activation, and Is Active in Patient-Derived Xenograft Models (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


4) Predictive Value of EGFL7 in mCRC (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


5) Pharmacogenetic Predictors in Early-Stage Colon Cancer (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


6) Biomarker for CBP501 (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


7) Combination of Quinacrine and Erlotinib in NSCLC (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


8) Novel Human Fusion Protein Kills EpCAM-Positive Cancer Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


9) CDK4/6 Inhibitor Reduces Human Liposarcoma Growth (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


10) Dose Schedule Optimization with Combined MLN8237 and Taxanes (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


11) Cyclopamine Glucuronide Prodrug toward Glioma Stem Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


12) NIR Fluorescent Choline Kinase Inhibitor (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


13) Axl Kinase as an Emerging Key Target for Drug Discovery (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


14) IL15-Secreting MSCs Exert Antitumor Potential (Molecular Cancer Therapeutics) Tuesday August 5th 2014


15) TDP1 and TDP2 Inhibitor Screening (Molecular Cancer Therapeutics) Tuesday August 5th 2014


16) CENP-E Motor Function in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Tuesday August 5th 2014


17) Mechanism of Action of the Novel Taxane Cabazitaxel (Molecular Cancer Therapeutics) Tuesday August 5th 2014


18) TGF-Stimulated Mesothelial Cells in Ovarian Cancer Progression (Molecular Cancer Therapeutics) Tuesday August 5th 2014


19) DDX43 Induces RAS Signaling and Drug Resistance (Molecular Cancer Therapeutics) Tuesday August 5th 2014


20) PP2A Inhibitor Sensitizes HCC to Chemotherapy (Molecular Cancer Therapeutics) Tuesday August 5th 2014


21) FAK Controls Ovarian Carcinoma Spheroid Growth (Molecular Cancer Therapeutics) Tuesday August 5th 2014


22) Activity of RG7787 in Pancreatic Cancer Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


23) Bispecific HER2-Targeting FynomAb with Superior Activity (Molecular Cancer Therapeutics) Tuesday August 5th 2014


24) s50-TBG-RNAi-CK2 Targets Primary and Metastatic HNSCC (Molecular Cancer Therapeutics) Tuesday August 5th 2014


25) Novel Drug for Treatment of Temozolomide-Resistant Gliomas (Molecular Cancer Therapeutics) Tuesday August 5th 2014


26) AKI603 Attenuates Breast Tumor Initiating Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


27) AR-42 Targets AML Stem Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


28) A Pragmatic Definition of Therapeutic Synergy (Molecular Cancer Therapeutics) Monday July 7th 2014


29) miR-3607 in Prostate Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


30) miR26b Regulates Cancer Proliferation (Molecular Cancer Therapeutics) Monday July 7th 2014


31) Repositioning Drugs for Renal Cell Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


32) Mutation Profile of Melanomas Lacking Known Driver Mutations (Molecular Cancer Therapeutics) Monday July 7th 2014


33) BET Bromodomain Inhibition and Pancreatic Cancer Progression (Molecular Cancer Therapeutics) Monday July 7th 2014


34) Antiproliferative Synergism of CK2 and BRAF Inhibitors (Molecular Cancer Therapeutics) Monday July 7th 2014


35) Targeting ER{beta} in SERM-Resistant Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


36) LXR Inhibition of Myeloma Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


37) SIRT1 in the Antitumor Activity of Silybin (Molecular Cancer Therapeutics) Monday July 7th 2014


38) ABT-737 Enhances MEK/mTOR Inhibition-Induced AML Apoptosis (Molecular Cancer Therapeutics) Monday July 7th 2014


39) PIK3R3 Induces EMT, Promoting Metastasis of Colorectal Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


40) MM-121 Combined with Cetuximab in HNSCC Preclinical Models (Molecular Cancer Therapeutics) Monday July 7th 2014


41) Prostate Cancer-Targeted Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


42) Pretargeted RIT of GD2 with an Anti-GD2/DOTA IgG-scFv (Molecular Cancer Therapeutics) Monday July 7th 2014


43) Anti-sEcad mAb-Induced Suppression of Skin SCCs (Molecular Cancer Therapeutics) Monday July 7th 2014


44) Generation of a Canine Anti-EGFR Antibody (Molecular Cancer Therapeutics) Monday July 7th 2014


45) Antibody-Based Delivery of IL2 and Cytotoxics (Molecular Cancer Therapeutics) Monday July 7th 2014


46) Targeting Pancreatic Cancer Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


47) Effect of Metronomic Docetaxel in PRINT Particles and siEZH2 (Molecular Cancer Therapeutics) Monday July 7th 2014


48) Redox-Active Cerium Oxide Nanoparticles in Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


49) Anti-miR182 Treatment in Ovarian Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


50) GGA Exerts Cardioprotective and Anticancer Effects (Molecular Cancer Therapeutics) Monday July 7th 2014


51) EW-7197, an Antimetastatic Drug in Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


52) Leelamine Inhibits Intracellular Cholesterol Transport (Molecular Cancer Therapeutics) Monday July 7th 2014


53) Targeting Melanomas Using Leelamine (Molecular Cancer Therapeutics) Monday July 7th 2014


54) Correction: Characterisation of the Novel Apoptotic and Therapeutic Activities of the Histone Deacetylase Inhibitor Romidepsin (Molecular Cancer Therapeutics) Thursday June 5th 2014


55) Efficacy of Zibotentan in Colorectal Cancer--Response (Molecular Cancer Therapeutics) Thursday June 5th 2014


56) Efficacy of Zibotentan in Colorectal Cancer--Letter (Molecular Cancer Therapeutics) Thursday June 5th 2014


57) 3D Environment in Chemoresistance of GBM Stem-like Cells (Molecular Cancer Therapeutics) Thursday June 5th 2014


58) ABT-737 Mediates Dislocation of ER Luminal Proteins (Molecular Cancer Therapeutics) Thursday June 5th 2014


59) PARP Inhibitors' Off-Target Effects (Molecular Cancer Therapeutics) Thursday June 5th 2014


60) Aflibercept versus Bevacizumab in PDX Colorectal Cancer Tumors (Molecular Cancer Therapeutics) Thursday June 5th 2014


61) MLN4924 DNA-Damaging Agent Combinations (Molecular Cancer Therapeutics) Thursday June 5th 2014


62) KRAS Status Predicts Antifolate Sensitivity (Molecular Cancer Therapeutics) Thursday June 5th 2014


63) Antibody-Drug Con{#x0237}ugate BRAF Inhibitor Combination (Molecular Cancer Therapeutics) Thursday June 5th 2014


64) Akt/Autophagy for Sorafenib Resistance in HCC (Molecular Cancer Therapeutics) Thursday June 5th 2014


65) Significance of the PELP1-mTOR Axis in Endocrine Resistance (Molecular Cancer Therapeutics) Thursday June 5th 2014


66) BAFF-R as Target for Antibody Therapy in ALL (Molecular Cancer Therapeutics) Thursday June 5th 2014


67) Noncytotoxic Treatment of Micrometastases (Molecular Cancer Therapeutics) Thursday June 5th 2014


68) AMG 330, a Novel CD3/CD33 BiTE Antibody (Molecular Cancer Therapeutics) Thursday June 5th 2014


69) Mesothelin-Targeting Antibody-Drug Con{#x0237}ugate (Molecular Cancer Therapeutics) Thursday June 5th 2014


70) Alternol Induces ROS-Dependent Apoptosis (Molecular Cancer Therapeutics) Thursday June 5th 2014


71) Tumor Targeting with Integrin {alpha}v{beta}3 and MMP-2 (Molecular Cancer Therapeutics) Thursday June 5th 2014


72) Immunotherapy for Hepatoma Using a Dual-Function Vector (Molecular Cancer Therapeutics) Thursday June 5th 2014


73) Small Molecule Inhibits ETV1 Acetylation and Function (Molecular Cancer Therapeutics) Thursday June 5th 2014


74) The JNK-MCL-1 Axis Contributes to the Anticancer Activity of MT189 (Molecular Cancer Therapeutics) Thursday June 5th 2014


75) Covalent EGFR Mutant-Selective Inhibitors (Molecular Cancer Therapeutics) Thursday June 5th 2014


76) A Small Molecule Inhibitor of EMT Pathways (Molecular Cancer Therapeutics) Thursday June 5th 2014


77) LY2857785 Is a CDK9 Inhibitor with Preclinical Antitumor Activity (Molecular Cancer Therapeutics) Thursday June 5th 2014


78) Coleusin Factor Restores Differentiation of Osteosarcoma (Molecular Cancer Therapeutics) Thursday June 5th 2014


79) Hec1 Inhibitor against Breast Cancer (Molecular Cancer Therapeutics) Thursday June 5th 2014


80) Inhibitors of Lactate Influx but Not Efflux (Molecular Cancer Therapeutics) Thursday June 5th 2014


81) Moguntinones--New Selective Inhibitors (Molecular Cancer Therapeutics) Thursday June 5th 2014


82) MELK, Key Kinase for Stem Cell Phenotype in Cancer Stem Cells (Molecular Cancer Therapeutics) Thursday June 5th 2014


83) Genomic Alterations of Primary and Recurrent Breast Cancer (Molecular Cancer Therapeutics) Tuesday May 6th 2014


84) Metallothioneins and Zinc Sensitize to Chemotherapy (Molecular Cancer Therapeutics) Tuesday May 6th 2014


85) nEGFR Is a Functional Molecular Target in TNBC (Molecular Cancer Therapeutics) Tuesday May 6th 2014


86) ERBB3 Signaling Promotes Resistance to EGFR Blockade (Molecular Cancer Therapeutics) Tuesday May 6th 2014


87) Cytosine Modifications in MGMT and Temozolomide Sensitivity (Molecular Cancer Therapeutics) Tuesday May 6th 2014


88) GALR2-Induced p38-MAPK Promotes Cytokine Secretion and Tumor (Molecular Cancer Therapeutics) Tuesday May 6th 2014


89) Hand-1 Suppresses Vascular Radiosensitivity (Molecular Cancer Therapeutics) Tuesday May 6th 2014


90) PUMA-Mediated Anticancer Effect of Aurora Kinase Inhibitors (Molecular Cancer Therapeutics) Tuesday May 6th 2014


91) The Role of TMEM98 in Chemoresistance of Hepatocellular Carcinoma (Molecular Cancer Therapeutics) Tuesday May 6th 2014


92) EMT Role in Docetaxel Resistance (Molecular Cancer Therapeutics) Tuesday May 6th 2014


93) The Hh Pathway and IPI-926 in Chondrosarcoma (Molecular Cancer Therapeutics) Tuesday May 6th 2014


94) JAK1/JAK2 Inhibition Suppresses Prostate Cancer Metastases (Molecular Cancer Therapeutics) Tuesday May 6th 2014


95) PIM Kinases Regulate CLL Survival and CXCR4 Surface Levels (Molecular Cancer Therapeutics) Tuesday May 6th 2014


96) Imatinib-Resistant Mast Cells Are Sensitive to Ponatinib (Molecular Cancer Therapeutics) Tuesday May 6th 2014


97) Embelin Reduces Colitis-Associated Tumorigenesis (Molecular Cancer Therapeutics) Tuesday May 6th 2014


98) Regulation of STAT5 Function by BRD2 in Leukemias (Molecular Cancer Therapeutics) Tuesday May 6th 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

Hack your inkjet printer and turn it into a lab robot

Is combustible dust a concern for research labs?

Update on Alnylam (And the Direction of Things to Come)

C−H Functionalization: Collaborative Methods to Redefine Chemical Logic

This week's C&EN

Photo

Happy Birthday to the man with five brains

Vehicles Responsible For More Particulate Pollution Than What Comes Out Of Their Tailpipes

CSB warns against using methanol in classroom or lab demos

What's wrong with this picture?

A sharper image for TV

Morning tidbit: 538 on why STEM is TE

There Must Have Been Multiple Chances to Catch This

Weirdly, Tramadol Is Not a Natural Product After All

FMC Changes Course


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()